Get the Stockscreener App
4.50
0.88%
-0.04
After Hours:
4.51
0.010
+0.22%
Treace Medical Concepts Inc stock is traded at $4.50, with a volume of 210.50K.
It is down -0.88% in the last 24 hours and down -6.44% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
See More
Previous Close:
$4.54
Open:
$4.55
24h Volume:
210.50K
Relative Volume:
0.41
Market Cap:
$292.66M
Revenue:
$207.32M
Net Income/Loss:
$-61.04M
P/E Ratio:
-4.6988
EPS:
-0.9577
Net Cash Flow:
$-25.97M
1W Performance:
+0.22%
1M Performance:
-6.44%
6M Performance:
+257.14%
1Y Performance:
-32.63%
1-Day Range:
$4.44
$4.645
1-Week Range:
$4.38
$4.67
52-Week Range:
$1.17
$7.08
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.50 | 292.66M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-07-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
Bank of America Corp DE Acquires 3,305,100 Shares of Treace Medical Concepts, Inc. $TMCI - MarketBeat
Investigation launched into Treace Medical offi... - Pluang
Did Treace Medical Concepts, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Treace Medical Concepts, Inc. (TMCI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Treace Medical Concepts, Inc. (TMCI) stock price, news, quote and history - Yahoo Finance UK
Treace Medical (TMCI) Reports Five-Year Bunion Results. Can Evidence Drive Adoption? - Insider Monkey
Treace Medical Looks Unlikely To Recover, A Founder-Led Broken Growth Story (NASDAQ:TMCI) - Seeking Alpha
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Unveiling A 21.41% Upside Potential - DirectorsTalk Interviews
Treace Medical Concepts Presents 5-Year ALIGN3D, 2-Year MTA3D and SPRINT Clinical Study Results at AOFAS Annual Meeting - Quiver Quantitative
Treace Medical Concepts Announces Results of Three Clinical Studies Including the Milestone Five-Year Align3d Study Demonstrating Sustained Positive Outcomes of the Lapiplasty Procedure - marketscreener.com
96.6% of patients showed healing after foot surgery - Stock Titan
Treace Highlights Product Innovations and Clinical Data Across its Expanding Foot & Ankle Portfolio at the 2026 AOFAS Annual Meeting - Orthopedics This Week
Treace Medical Concepts to Showcase New Foot and Ankle Innovations and Clinical Data at AOFAS 2026 - Quiver Quantitative
New bunion tools and five-year study results will be shown in Seattle - Stock Titan
BlackRock Inc. Takes Position in Treace Medical Concepts, Inc. $TMCI - marketbeat.com
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Recommendation of "Reduce" by Analysts - marketbeat.com
TMCI IMPORTANT DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 10 Deadline in Securities Class ActionTMCI - TMX Newsfile
Treace Medical (TMCI) Holds Gains: Stock Rises 1.09% as $4.42 Support Anchors the ChartMerger Arbitrage - vinanet.vn
Bank of America Corp DE Has $4.31 Million Stock Holdings in Treace Medical Concepts, Inc. $TMCI - marketbeat.com
Treace Medical Concepts (TMCI) Gains 0.87% as Shares Approach Key Resistance at $4.87Trend Reversal Picks - siam.in
TMCI Q2 2026 Earnings: Loss Narrows More Than Expected, Driving Modest Share GainsEarnings Decline Risk - dars.gov.et
SNDL And 2 Other Promising Penny Stocks To Watch - simplywall.st
Treace Medical (TMCI) CEO adds to stake with late‑August buys - Stock Titan
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Ge - natlawreview.com
TMCI senior director charged with insider trading in U.S. - Peoples Gazette Nigeria
Exec charged for trading ahead of dismal results - Investment Executive
Did You Lose Money on Treace Medical Concepts, Inc. (TMCI)? Levi - The National Law Review
Treace Medical Concepts Earnings Call Signals Cautious Rebound - TipRanks
Medical Device Exec Cashed In On Bad Quarter, Feds Charge - Law360
522,900 Shares in Treace Medical Concepts, Inc. $TMCI Purchased by Renaissance Technologies LLC - MarketBeat
TMCI Q2 2026 Earnings: EPS Beat Drives 6.2% Stock Uptick as Losses NarrowProfit Warning Alert - vinanet.vn
Armistice Capital (TMCI) discloses 6.36M-share Treace Medical ownership stake - Stock Titan
Treace Medical Concepts (TMCI) officer disposes shares for tax or exercise costs - Stock Titan
Treace Medical Concepts (TMCI) CEO John T. Treace reports 19.2% beneficial stake - Stock Titan
Treace Medical Concepts (TMCI) CFO uses 37,102 shares to cover equity-related taxes - Stock Titan
Treace Medical Concepts (TMCI) officer uses 16,253 shares for tax or exercise costs - Stock Titan
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50 - simplywall.st
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Given Consensus Rating of "Reduce" by Analysts - marketbeat.com
Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial - MarketBeat
Truist Securities Adjusts PT on Treace Medical Concepts to $5 From $4, Keeps Hold Rating - marketscreener.com
Treace Medical Concepts (TMCI) Stock Jumps As Cash Burn Eases But Sales Stall - Sahm
Treace Medical Concepts: Q2 Earnings Snapshot - theheraldreview.com
Treace Medical Concepts (NASDAQ:TMCI) Posts Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.51%
0.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):